Glucose Health Inc (GLUC)

[$b_rich$]

SECTION 1. REGISTRANT’S BUSINESS AND OPERATIONS

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

The Board of Directors of Bio-Solutions Corp., a Nevada corporation (the "Company"), approved the execution of that certain marketing services agreement dated July 24, 2013 (the "Marketing Services Agreement") with Damon R. Devitt ("Devitt"). During September 2011, the Company acquired all the assets and intellectual property rights to Type2 Defense™ (the “Product”), which is a glucose control dietary supplement powder formulated to support healthy glucose levels for type 2 diabetics and pre-diabetics in addition to maintaining healthy blood pressure. The Product is also effective in controlling hypertension and has strong antioxidant powers. Management believes that there is a growing marketplace that lacks adequate healthy tools to maintain healthy blood glucose levels and intends to market and sell the Product on the Internet.

In accordance with the terms and provisions of the Marketing Services Agreement, Devitt shall provide certain services to the Company which include, but are not limited to, the following: (i) create and produce a 30-minute infomercial for the Product with the goal of developing product messaging and positioning that is integrated with corporate strategy and achievement of short and long term sales objectives: (ii) create and produce an abridged version of the infomercial for Internet marketing on social networks; (iii) create and develop a four color print advertisement targeting specific magazines; and (iv) provide media buying services for placement of the infomercial. In further accordance with the terms and provisions of the Marketing Services Agreement, the Company shall pay to Devitt a production fee, which shall consist of the issuance to Devitt of an aggregate 15,000,000 shares of common stock of which 7,500,000 shares shall be issued within three business days of execution of the Marketing Services Agreement and the remaining 7,500,000 shares shall be issued upon completion of the infomercial. All shares of common stock issued to Devitt shall be subject to a registration statement on Form S-8.

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9437147



200M A/S per Nevada SOS:

http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=EjE1biEdM3imK4kDNYEK4A%253d%253d&nt7=0